SR-8291

N/A

Report date: 2025/01/26 16:43:15
NME

Base Information

Drug NameSR-8291
Drug Alias NameSTING agonist (Stingray Therapeutics)ectonucleotide pyrophosphatase-PDE-1 inhibitor (Stingray Therapeutics)SR-8291
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitorsStimulator of interferon genes stimulants
TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1Stimulator of interferon genes
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStingray Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStingray Therapeutics
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A